Mail

UK markets closed

FTSE 100
8,213.49
+41.34(+0.51%)
FTSE 250
20,164.54
+112.21(+0.56%)
AIM
771.53
+3.42(+0.45%)
GBP/EUR
1.1652
-0.0031(-0.26%)
GBP/USD
1.2546
+0.0013(+0.11%)
Bitcoin GBP
50,391.44
+3,104.78(+6.57%)

Best savings accounts that offer above inflation rates

Where to find a top-rated deal that works for you

Pliant Therapeutics, Inc. (PLRX)

NasdaqGS - NasdaqGS Real-time price. Currency in USD

Add to watchlist

13.98

+0.73

(+5.51%)

At close: 04:00PM EDT

13.98

0.00

(0.00%)

After hours:

04:01PM EDT

Currency in USD

Valuation measures⁴

Market cap (intra-day)	843.26M
Enterprise value	360.38M
Trailing P/E	49.43
Forward P/E	N/A
PEG ratio (5-yr expected)	N/A
Price/sales (ttm)	519.55
Price/book (mrq)	1.78
Enterprise value/revenue	228.09
Enterprise value/EBITDA	-2.28

Trading information

Stock price history

Beta (5Y monthly)	1.12
52-week change ³	-40.05%
S&P500 52-week change ³	22.38%
52-week high ³	24.74
52-week low ³	11.21
50-day moving average ³	14.45
200-day moving average ³	15.88

Share statistics

Avg vol (3-month) ³	378.68k
Avg vol (10-day) ³	381.61k
Shares outstanding ⁵	60.32M
Implied shares outstanding ⁶	60.32M
Float ⁸	47.11M
% held by insiders ¹	6.62%
% held by institutions ¹	111.38%
Shares short (15 Apr 2024) ⁴	7.62M
Short ratio (15 Apr 2024) ⁴	22.86
Short % of float (15 Apr 2024) ⁴	12.88%
Short % of shares outstanding (15 Apr 2024) ⁴	12.65%
Shares short (prior month 15 Mar 2024) ⁴	7M

Dividends & splits

Forward annual dividend rate ⁴	N/A
Forward annual dividend yield ⁴	N/A
Trailing annual dividend rate ³	0.00
Trailing annual dividend yield ³	0.00%
5-year average dividend yield ⁴	N/A
Payout ratio ⁴	0.00%
Dividend date ³	N/A
Ex-dividend date ⁴	N/A
Last split factor ²	N/A
Last split date ³	N/A

Financial highlights

Fiscal year

Fiscal year ends	31 Dec 2023
Most-recent quarter (mrq)	31 Dec 2023

Profitability

Profit margin	0.00%
Operating margin (ttm)	-11,654.75%

Management effectiveness

Return on assets (ttm)	-26.68%
Return on equity (ttm)	-41.01%

Income statement

Revenue (ttm)	1.58M
Revenue per share (ttm)	0.03
Quarterly revenue growth (yoy)	-100.00%
Gross profit (ttm)	N/A
EBITDA	-182.3M
Net income avi to common (ttm)	-161.34M
Diluted EPS (ttm)	-2.75
Quarterly earnings growth (yoy)	N/A

Balance sheet

Total cash (mrq)	494.24M
Total cash per share (mrq)	8.2
Total debt (mrq)	11.37M
Total debt/equity (mrq)	2.40%
Current ratio (mrq)	17.72
Book value per share (mrq)	7.90

Cash flow statement

Operating cash flow (ttm)	-116.36M
Levered free cash flow (ttm)	-66.86M